Multi-rAb CoraLite® Plus 488-Goat Anti-Mouse Recombinant Secondary Antibody (H+L)
Multi-rAb Goat Anti-Mouse Recombinant Secondary Antibody (H+L) is a mixture of precisely engineered recombinant monoclonal antibodies that recognize multiple complementary epitopes on the mouse IgG heavy and light chains.
Cat no : RGAM002
Validation Data Gallery
Product Information
RGAM002 targets Mouse IgG (H+L) in FC and IF. It can bind to all mouse IgG isotypes, mouse IgM and IgA as well as rat IgG. It shows minimal reactivity for rabbit, human, pig and bovine IgGs.
| Concentration | 0.5 mg/mL |
| Applications | IF, FC |
| Host Species | Goat |
| Species Reactivity | Mouse |
| Physical State | Liquid |
| Suggested Dilution Range | 1:200-1:1000 for IF and FC |
| Purity | The antibody was purified from culture media supernatant by immunoaffinity chromatography using Protein G beads. |
| Storage Buffer | PBS with 50% glycerol, 10 mg/mL BSA, 0.1% Proclin-300, pH 7.4. |
| Storage Instructions | Store at -20°C. Stable for one year after shipment. |
| Fluorophore | CoraLite® Plus 488, Amax=493 nm, Emax=522 nm |
| Clonality | Multiclonal recombinant |
| RRID | AB_3068538 |
| Note | This product is for research use only,not for diagnostic or therapeutic use. |
Background
Multi-rAb Recombinant Secondary Antibodies are mixtures of precisely engineered recombinant monoclonal antibodies that recognize multiple complementary epitopes on the same IgG. Each recombinant clone in the final multiclonal mixture is carefully selected after rigorous characterization and screening to ensure the highest level of performance. The selected clones are mixed in various combinations, each of which is then functionally characterized in multiple applications to select the final multiclonal mixture with optimal performance.
Each lot of Multi-rAb Secondary Antibodies is produced by mixing the same high performing recombinant clones every time to ensure that they have high batch-to-batch consistency, which in turn results in high reproducibility of experimental data.
Publications
| Title |
|---|
Drug Resist Updat Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration |
Adv Healthc Mater Controlled Release of Ceria and Ferric Oxide Nanoparticles via Collagen Hydrogel for Enhanced Osteoarthritis Therapy |
Mol Neurobiol Rosiglitazone Promotes Oligodendrocyte Development and Myelin Formation of Repeated Neonatal Sevoflurane Exposure via PPARγ Signaling |
Cell Death Dis CHIP-mediated ubiquitin degradation of BCAT1 regulates glioma cell proliferation and temozolomide sensitivity |
Aging (Albany NY) The protective effects of Irbesartan in cognitive impairment in hypertension |
Drug Des Devel Ther Propofol and Dexmedetomidine Ameliorate Endotoxemia-Associated Encephalopathy via Inhibiting Ferroptosis |